Diploma (LON:DPLM) Shares Break Above Two Hundred Day Moving Average – What’s Next?

Diploma PLC (LON:DPLM)’s share price passed above its two hundred day moving average during trading on Tuesday. The stock has a two hundred day moving average of GBX 7,164.03 and traded as high as GBX 7,785. Diploma shares last traded at GBX 7,485, with a volume of 415,158 shares trading hands.

Wall Street Analyst Weigh In

DPLM has been the topic of a number of recent analyst reports. Berenberg Bank reiterated a “buy” rating and set a GBX 9,000 price target on shares of Diploma in a research report on Monday, July 20th. Royal Bank Of Canada restated an “outperform” rating and issued a GBX 7,400 price objective on shares of Diploma in a research report on Tuesday, September 8th. Finally, JPMorgan Chase & Co. boosted their price objective on Diploma from GBX 5,760 to GBX 8,250 and gave the company an “overweight” rating in a research report on Monday, August 24th. Six research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of GBX 7,400.

Diploma Price Performance

The company has a quick ratio of 0.80, a current ratio of 2.06 and a debt-to-equity ratio of 47.65. The stock has a market capitalization of £9.74 billion, a PE ratio of 51.56, a PEG ratio of 2.82 and a beta of 0.92. The company has a 50-day moving average of GBX 7,447.88 and a 200 day moving average of GBX 7,181.23.

Insider Activity

In other Diploma news, insider Katie Bickerstaffe  bought 246 shares of the company’s stock in a transaction dated Wednesday, September 23rd. The stock was acquired at an average price of GBX 7,696 per share, with a total value of £18,932.16. 1.14% of the stock is owned by insiders.

Diploma Company Profile

Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.